How should a child with a scaly, itchy facial rash due to a fungal infection (tinea faciei) be treated?

Treatment of Tinea Faciei in Children

For a child with scaly, itchy facial fungal infection (tinea faciei), topical antifungal therapy is the appropriate first-line treatment, unlike scalp infections which require oral therapy. While the available guidelines focus on tinea capitis (scalp), tinea faciei (face) is a distinct entity affecting glabrous (non-hair-bearing) skin and responds well to topical treatment 1, 2, 3.

Key Diagnostic Considerations

Before initiating treatment, consider:

• Most common pathogens in children: Microsporum canis (especially with pet exposure), Trichophyton rubrum, and Trichophyton mentagrophytes 1, 2
• Pet history is critical: 54-91% of pediatric tinea faciei cases involve contact with infected animals, particularly cats, dogs, and rabbits 2, 4
• Confirm diagnosis: Obtain KOH preparation or fungal culture when possible, especially if presentation is atypical 3

Important Clinical Pitfall: Tinea Incognito

Stop any topical steroids immediately if they have been used. Tinea faciei frequently mimics eczema, atopic dermatitis, or lupus erythematosus, leading to inappropriate steroid use that worsens the infection and creates "tinea incognito" 2, 5. This is particularly common in children and delays proper treatment.

Treatment Algorithm

First-Line: Topical Antifungal Therapy

Use topical antifungal agents as primary treatment for tinea faciei:

• Topical allylamines (terbinafine cream) or azoles (clotrimazole, miconazole, ketoconazole) applied twice daily
• Allylamines are fungicidal and may have slightly higher cure rates with shorter treatment courses than fungistatic azoles 3
• Continue treatment for 2-4 weeks, extending beyond clinical resolution to ensure mycological cure
• Topical therapy shows favorable outcomes in tinea faciei 1

When to Consider Oral Therapy

Oral antifungals are reserved for:

• Extensive facial involvement
• Vellus hair follicle involvement (documented in 39% of pediatric cases) 2
• Treatment failure with topical agents
• Concurrent tinea capitis or other body sites requiring systemic treatment

If oral therapy is needed, follow species-specific guidelines 6:

• For Trichophyton species: Terbinafine (weight-based dosing: <20 kg: 62.5 mg/day; 20-40 kg: 125 mg/day; >40 kg: 250 mg/day for 2-4 weeks)
• For Microsporum species: Griseofulvin (15-20 mg/kg/day for 6-8 weeks) is more effective

Additional Management Measures

Adjunctive topical therapy to reduce spore transmission:

• Ketoconazole 2% shampoo or selenium sulfide 1% shampoo can be used on affected areas 6

Address infection source:

• Examine and treat infected pets (veterinary referral required) 2
• Screen family members, especially with anthropophilic species like T. tonsurans 6
• Disinfect fomites (combs, towels) with bleach solution 6

Follow-Up and Monitoring

• Mycological cure is the endpoint, not just clinical improvement 6
• Patients with cheek lesions have higher recurrence rates (33.3%) and may require longer treatment 1
• History of previous fungal infection increases recurrence risk 1
• Children can attend school during treatment 6

Red Flags Requiring Closer Monitoring

• Male gender, prior fungal infection history, and cheek involvement are significantly associated with recurrent infection 1
• Previous topical steroid use may prolong time to mycological cure 1
• Inflammatory presentations from zoophilic dermatophytes (especially rabbit-associated T. mentagrophytes) can be severe and require prompt recognition 4